慢性乙型肝炎患者的肝硬化和肝细胞癌发生率及监测的作用：673例患者的10年随访 - Suppr | 超能文献

Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.

作者信息

Basyigit Sebahat, Sapmaz Ferdane

机构信息

Department of Gastroenterology, Kecioren Research and Training Hospital, Ankara, Turkey.

出版信息

Eur J Gastroenterol Hepatol. 2015 Oct;27(10):1230. doi: 10.1097/MEG.0000000000000426.

DOI:10.1097/MEG.0000000000000426

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.慢性乙型肝炎患者的肝硬化和肝细胞癌发生率及监测的作用：673例患者的10年随访

Eur J Gastroenterol Hepatol. 2015 Oct;27(10):1230. doi: 10.1097/MEG.0000000000000426.

2

[Incidence of hepatocellular carcinoma in chronic infection with hepatitis B].慢性乙型肝炎感染中肝细胞癌的发病率

Pan Afr Med J. 2015 Feb 23;20:167. doi: 10.11604/pamj.2015.20.167.6227. eCollection 2015.

3

Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.慢性乙型肝炎患者长期肝硬化和肝细胞癌风险的预测模型：整合宿主和病毒特征的风险评分。

Hepatology. 2013 Aug;58(2):546-54. doi: 10.1002/hep.26385.

4

[Study on the natural history of chronic hepatitis B].[慢性乙型肝炎自然史的研究]

Zhonghua Gan Zang Bing Za Zhi. 2002 Feb;10(1):46-8.

5

Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.长期使用富马酸替诺福韦二吡呋酯对慢性乙型肝炎患者肝细胞癌发生率的影响。

Cancer. 2015 Oct 15;121(20):3631-8. doi: 10.1002/cncr.29537. Epub 2015 Jul 15.

6

Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study.恩替卡韦治疗慢性乙型肝炎患者时观察到较低的肝细胞癌发病率：ENUMERATE研究结果

Am J Gastroenterol. 2016 Sep;111(9):1297-304. doi: 10.1038/ajg.2016.257. Epub 2016 Jun 21.

7

Long-term effect of interferon therapy on incidence of cirrhosis and hepatocellular carcinoma in Thai patients with chronic hepatitis B.干扰素治疗对泰国慢性乙型肝炎患者肝硬化和肝细胞癌发生率的长期影响。

Southeast Asian J Trop Med Public Health. 2001 Sep;32(3):452-8.

8

Hepatocellular carcinoma risk stratification in HBV cirrhosis: Time to turn the page?乙肝肝硬化患者肝细胞癌的风险分层：是时候翻开新篇章了吗？

J Hepatol. 2020 Sep;73(3):728-729. doi: 10.1016/j.jhep.2020.04.018. Epub 2020 May 15.

9

Reply to: "Hepatocellular carcinoma risk stratification in HBV cirrhosis: Time to turn the page".回复：“乙肝肝硬化患者肝细胞癌风险分层：是时候翻开新篇章了”。

J Hepatol. 2020 Sep;73(3):729-730. doi: 10.1016/j.jhep.2020.04.029. Epub 2020 May 15.

10

Delayed viral suppression during antiviral therapy is associated with increased hepatocellular carcinoma rates in HBeAg-positive high viral load chronic hepatitis B.在HBeAg阳性、高病毒载量的慢性乙型肝炎患者中，抗病毒治疗期间病毒抑制延迟与肝细胞癌发生率增加相关。

J Viral Hepat. 2018 May;25(5):552-560. doi: 10.1111/jvh.12838. Epub 2018 Mar 14.

引用本文的文献

1

Real-World Epidemiology, Clinical and Economic Burden of Chronic Hepatitis B in Japan: A Retrospective Study Using JMDC Claims Database.日本慢性乙型肝炎的真实世界流行病学、临床和经济负担：一项使用JMDC理赔数据库的回顾性研究

Infect Dis Ther. 2023 May;12(5):1337-1349. doi: 10.1007/s40121-023-00795-0. Epub 2023 Apr 17.

2

Predictive value of the preoperative neutrophil-to-lymphocyte ratio for the development of hepatocellular carcinoma in HBV-associated cirrhotic patients after splenectomy.术前中性粒细胞与淋巴细胞比值对乙型肝炎相关肝硬化患者脾切除术后发生肝细胞癌的预测价值。

PLoS One. 2018 Apr 5;13(4):e0195336. doi: 10.1371/journal.pone.0195336. eCollection 2018.